Amendment No. 1 - Question Answer.pdf

PDF 65 KB Posted

Attached to
Triple Quadrupole Mass Spectrometer Coupled with HPLC System Federal contract opportunity
Solicitation number
FDA-RFP-1223268R
Issued by
Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services

About this file

This document contains an amendment and questions and answers related to a solicitation. The solicitation, number FDA-RFP-1223268R, is seeking to provide one unit of a Triple Quadrupole Mass Spectrometer Coupled with HPLC System. The Food and Drug Administration changed the evaluation criteria to clarify how the system will be evaluated for sensitivity and that the award determination is now best value instead of a two-phase process. Bidders with a new product entering the market may submit two separate proposals in response. The questions and answers clarify that bidders are not required to conduct new testing but can resubmit previous results, and any tests not compliant with the attachment will be eliminated from consideration.

View the file

Other files for this federal contract opportunity

Other files attached to Triple Quadrupole Mass Spectrometer Coupled with HPLC System, newest first.
File Type Posted
Attachment 1 - Testing Instructions.pdf PDF
FDA-RFP-1223268R.pdf PDF

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Amendment No: 1

Question & Answers

FDA-RFP-1223268R – Amendment No: 1

Triple Quadrupole Mass Spectrometer Coupled with HPLC System

Questions & Answers

Q 1. Our original submission met all of the new requirements issued. Please advise if we need to re-run the samples with the purchased standards called out in the new procedures.

A1. Per our instructions in Part 7. You are not required to conduct new test but can re-submit the previous test result along with your proposal. In accordance with Part 8 any testing performed that was not in compliance with Attachment 1 will be eliminated from competition.

Q 2. Between the previous submission and now when the revision come out, we have had a new product enter the market. Is the FDA willing to receive two proposal options, as a submission RFP FDA-1223268R? We should be able to run the required tests this week, for submission next week. If acceptable, would it be preferred to have everything under one proposal, or have a set of two?

A2 We prefer to have two (2) separate set of proposals.

End of Question & Answers

File details come from the government source that posted it. Updated .